Current status of interleukin-10 and regulatory T-cells in cancer

Interleukin-10 and the Interleukin-10 Receptor

Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737

Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells

Park, J., Adoro, S., Guinter, T. I., Erman, B., Alag, A., Catálfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · cited 1×

The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells

Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145

Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages

Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742

A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17

Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265

A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene

Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039

IL-10 inhibits cytokine production by activated macrophages

Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Fiorentino, D. F., Bond, M. W., & Mosmann, T. R. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.170.6.2081 · Cited by 2,733

Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells

Pasare, C., & Medzhitov, R. M. (2003) · Science · doi:10.1126/science.1078231 · Cited by 2,000

Potential roles for efferocytosis in glioblastoma immune evasion

Lorimer, I. A. J. (2024) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdae012 · Cited by 6

A dual-role for IL-10: From leukemogenesis to the tumor progression in acute lymphoblastic leukemia

Silva, F. S., Lima, A. B., Souza-Barros, M., Crespo-Neto, J. A., Santos, V. G. R., Pereira, D. S., Alves-Hanna, F. S., Magalhães-Gama, F., Faria, J. A. Q. A., & Costa, A. G. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156371 · Cited by 5

Immune Evasion in Cancer Is Regulated by Tumor-Asociated Macrophages (TAMs): Targeting TAMs

Jung, M., & Bonavida, B. (2024) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2024053096 · Cited by 5

Cytokine Therapy in Bladder Cancer: Mechanisms, Efficacy, and Future Prospects

Oyler, H. J., Bruton, L. G., Maher, A. J., Yu, D., Shely, N. W., Wakefield, M. R., & Fang, Y. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040278 · Cited by 5

Augmentation of lymphocytes activation and T cell modulation by the extracts from someEuphorbiaspecies

Ghafourian, M., Khosravi, N., Malek-Hosseini, S., & Amirghofran, Z. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.898077 · Cited by 5

Detecting Secreted Analytes from Immune Cells: An Overview of Technologies

Pike, K. A., Hui, C., & Krawczyk, C. M. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3801-8_9 · Cited by 5

Vitamin D insufficiency correlates with peripheral B10 cells in patients with pituitary tumours

Wang, W., Fu, L., Li, S., Xu, Z., Qiu, P., Xu, T., Yang, W., Zhang, Y., Xu, G., Lu, X., et al. (2017) · Cell Biochemistry and Function · doi:10.1002/cbf.3270 · Cited by 5

B Cells and Melanoma Pathogenesis

Aira, L. E., & Debes, G. F. (2019) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2019.03.1131 · Cited by 5

In Vitro Evidence of Differential Immunoregulatory Response between MDA-MB-231 and BT-474 Breast Cancer Cells Induced by Bone Marrow-Derived Mesenchymal Stromal Cells Conditioned Medium

Arenas-Luna, V. M., Montesinos, J. J., Cortés-Morales, V. A., Navarro‐Betancourt, J. R., Peralta-Ildefonso, J., Cisneros, B., & Hernández-Gutiérrez, S. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb45010020 · Cited by 5

Role of elevation of glycolysis in tumor-associated macrophages in glioblastoma immune evasion and therapeutic implications

Chen, J., Zhu, L., Lawson, T., Proud, C. G., & Dai, L. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgaf396 · Cited by 4

Immuno-radiobiology: Effects of Radiation Therapy on Immune Cells, Tumor Microenvironment, Susceptibility of Tumor Cells to Immune-mediated Destruction, and Antitumor Immunity

Wang, Y., Berg, T. J., Verona, A., & Morris, Z. S. (2026) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2026.01.013 · Cited by 4

Clinical Outcomes and Genomic Alterations in Gleason Score 10 Prostate Cancer

Chen, L. W., Tuaç, Y., Li, S. L., Leeman, J. E., King, M. T., Orio, P. F., Nguyen, P. L., D'Amico, A. V., Aktan, Ç., & Sayan, M. (2025) · Cancers · doi:10.3390/cancers17071055 · Cited by 4

Effects of anticipated neonatal surgical intervention on maternal milk cytokine production

Rentea, R. M., Wagner, A. J., Gourlay, D. M., Christensen, M. A., & Liedel, J. (2016) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2016.10.017 · Cited by 4

Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation

Yoon, S., & Eom, G. H. (2020) · Chonnam Medical Journal · doi:10.4068/cmj.2020.56.1.6 · Cited by 4

A Five Collagen-Related Gene Signature to Estimate the Prognosis and Immune Microenvironment in Clear Cell Renal Cell Cancer

Shi, X., Zhou, X., Yue, C., Lu, C., Gao, S., Zuo, L., Sun, Z., & Zhang, L. (2021) · Vaccines · doi:10.3390/vaccines9121510 · Cited by 4

Anti-Oxidant, Pro-Oxidant and Anti-Inflammatory Effects of Unpolished Rice Relevant to Colorectal Cancer

Suwannalert, P., Payuhakrit, W., & Koomsang, T. (2016) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2016.17.12.5047 · Cited by 4

Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models

Settanni, C. R., Quaranta, G., Bibbò, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02631-x · Cited by 4

TP53TG1/STAT axis is involved in the development of colon cancer through affecting PD-L1 expression and immune escape mechanism of tumor cells.

Ji, W., Wang, W., & Wei, Y. (2023) · PubMed Central · Cited by 3

Expression Profile of IL-2, IL-6, IL-10, and TNF-α in Breast Tumors

dos Santos, H. W. G., Bramante, B. C., Perez, M. M., da Veiga, G. L., Alves, B. D. C. A., & Fonseca, F. L. A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167841 · Cited by 3

The Tumor Environment in Peritoneal Carcinomatosis and Malignant Pleural Effusions: Implications for Therapy

Mirsky, P. O., Wagner, P. L., Mandic-Popov, M., Donnenberg, V. S., & Donnenberg, A. D. (2025) · Cancers · doi:10.3390/cancers17193217 · Cited by 4

The Influence of Gastrodin on Expression of IL-10, STAT3 and JAK2 in Epileptic Rats’ Hippocampus

Li, X., & Cheng, X. (2018) · Yangtze Medicine · doi:10.4236/ym.2018.21002 · Cited by 3

Recent advances in molecular diagnostics and therapeutic targets for pancreatic cancer

Clay, R., & Siddiqi, S. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819457-7.00016-5 · Cited by 3

Ovarian cancer and inflammation. Part 2. Anti-inflammatory cytokines

Terlikowska, K. M., Dobrzycka, B., & Terlikowski, S. J. (2018) · Progress in Health Sciences · doi:10.5604/01.3001.0012.8348 · Cited by 3

Obstacles in the Development of Therapeutic Cancer Vaccines

Keshavarz‐Fathi, M., & Rezaei, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814039-0.00012-6 · Cited by 3

Omega-3 fatty acid supplementation – A possible dietary adjunct to enhance immune checkpoint inhibition therapy in cancer?

Wachtel, N., Rohwer, N., Pietzner, A., Loew, A., & Weylandt, K. H. (2019) · Journal of Cellular Biotechnology · doi:10.3233/jcb-180013 · Cited by 5

Gene set based systematic analysis of prostate cancer and its subtypes

Ye, S., Wang, H., He, K., Shen, H., Peng, M., Nian, Y., Cui, R., & Lu, Y. (2019) · Future Oncology · doi:10.2217/fon-2019-0459 · Cited by 3

MicroRNA-98 as a novel diagnostic marker and therapeutic target in cancer patients

Akhlaghipour, I., & Moghbeli, M. (2024) · Discover Oncology · doi:10.1007/s12672-024-01270-z · Cited by 3

Prognostic Role of Human Leukocyte Antigen Alleles and Cytokine Single-Nucleotide Polymorphisms in Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitor Drugs

Birru, S. K., Doxiadis, I. I. N., Howe, R., Kelemu, T., Hailu, S., Sherif, A., Tadesse, F., Tsegaye, A., Gebremedhin, A., & Lehmann, C. (2024) · Genes · doi:10.3390/genes15060732 · Cited by 2

Neutrophil-to-lymphocyte ratio is associated with accelerometer-measured physical activity levels in breast cancer survivors

Álvarez‐Bustos, A., Romero-Elias, M., García, S. R., Méndez-Otero, M., Cebolla‐Boado, H., Sánchez, A., Navarro, R., & Ruiz‐Casado, A. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09233-y · Cited by 2

Targetting Interleukins Involved in Glioblastoma – A New Pharmacological Approach

Masood, A. B., Kayani, M. A., & Batool, S. (2020) · Journal of Life and Bio Sciences Research · doi:10.38094/jlbsr1330 · Cited by 2

Modulating gut immunity and neoplasia with oral cytokine adjuvants

Özbilge, H., LeVea, C., Chung, A. Y., Li, Q., & Egilmez, N. K. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.1002724 · Cited by 2

Cancer research driven by cutting-edge multi-disciplinary technologies

Lyu, Q., Feng, Y., Shi, R., Wu, J., & Han, W. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0638 · Cited by 2

Evaluation of PD-1 and interleukin-10-receptor expression by T lymphocytes in malignant and benign pleural effusions

Mosleh, B. O., Hammer, B. O., El‐Gazzar, A., Kramer, M., Ayazseven, S., Bernitzky, D., Geleff, S., Idzko, M., Gompelmann, D., & Hoda, M. A. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01485-y · Cited by 1

Assessment of Cancer biomarkers and biochemical parameters across breast Cancer stages: Correlation with age and comorbidities

Darweesh, O., & Al-Nori, M. K. J. (2025) · Cytokine · doi:10.1016/j.cyto.2025.156997 · Cited by 1

Cytokine Regulation and Oxidative Stress in Helicobacter Pylori-Associated Gastric Adenocarcinoma at Different Stages: Insights from a Cross-Sectional Study

Smirnova, O. V., Sinyakov, A. A., & Каспаров, Э. В. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157609 · Cited by 1

PVA‐co‐PAMPS Membranes with Selective Anticancer Activity and Metabolic Stimulation of Healthy Cells

Varguez‐Catzim, P., González‐Díaz, M. O., Claudio‐Rizo, J. A., León‐Campos, M. I., Huhn‐Ibarra, M., & Aguilar-Vega, M. J. (2025) · Advanced Therapeutics · doi:10.1002/adtp.202500178 · Cited by 1

Characteristics of Peripheral Blood Lymphocyte Populations in Patients with Locally Advanced Unresectable Non-Small Cell Lung Cancer

Grivtsova, L. Y., Glukhareva, A. E., Aa, M., Mushkarina, Т. Y., Afonin, G. V., Efremova, A. S., Иванов, С. А., Goldshtein, D. V., & Каприн, А. Д. (2025) · Cancers · doi:10.3390/cancers17213504 · Cited by 1

Breast cancer microenvironment composition associated with high PD-L1 expression

Chekhun, V. F., Lukianova, Y., Mushii, O., Zadvornyi, T., Pavlova, A., Burda, T., Bazas, V., Shepelenko, I. V., & Lukianova, N. Y. (2026) · BMC Cancer · doi:10.1186/s12885-026-15542-0 · Cited by 1

Mechanisms of Therapeutic Resistance and Recent Advances in Glioblastoma Treatment

Achari, E., Ahmady, F., Sharma, A., Schmidt‐Wolf, I. G. H., Maciaczyk, J., Luwor, R. B., & Achuthan, A. A. (2026) · Immunology and Cell Biology · doi:10.1111/imcb.70144 · Cited by 2

Cell and Tissue Destruction in Selected Disorders

Arnhold, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816388-7.00009-7 · Cited by 1

Impacts of Interleukin-10 Promoter Genotypes on Prostate Cancer

CHIN, Y.-T., Tsai, C.-L., Ma, H.-H., Cheng, D., Tsai, C.-W., WANG, Y.-C., SHIH, H.-Y., Chang, S.-Y., Gu, J. H., Chang, W. S., et al. (2024) · Life · doi:10.3390/life14081035 · Cited by 1

Transforming cancer immunotherapy: Overcoming immunosuppression in tumors via gene silencing techniques based on nanoparticles

Saha, P., Hasib, M. A., Halder, B., Sultana, S., & Rafe, M. R. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.106589 · Cited by 2

Regulatory T Cells: Their Role, Mechanism of Action, and Impact on Cancer

Cillo, A. R., & Vignali, D. A. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_6 · Cited by 1

POTENSI LACTOBACILLUS PLANTARUM SEBAGAI INTERVENSI PENATALAKSANAAN KANKER KOLOREKTAL BERBASIS MODIFIKASI MIKROBIOTA USUS

Indrakusuma, A. A. B. P., Sadeva, I. G. K. A., Wulandari, P. A., Wiguna, I. G. W. W., Remitha, N. P. S. I., Sadvika, I. G. A. S., Supadmanaba, I. G. P., & Wihandani, D. M. (2020) · Jurnal Kesehatan · doi:10.24252/kesehatan.v13i2.17044 · Cited by 1

Therapeutic Vaccines for Gastrointestinal Malignancies

Bonala, S., Tatireddigari, V. R. R. A., & Vadde, R. (2020) · Diagnostics and therapeutic advances in GI malignancies · doi:10.1007/978-981-15-6487-1_8 · Cited by 1

Nanotechnology-based interventions for interactions with the immune system

Saha, S., Dasgupta, S., & Barui, A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822858-6.00013-3 · Cited by 1

Improvement of adoptive T-cell therapy for Cancer

Jin, C. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

The role of angiopoietin-like 4 in inflammation

Phua, T. (2017) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/72319

Controle da imunossupressão como estratégia para potencializar os efeitos de uma vacina de DNA contra tumores induzidos pelo HPV-16.

da Silva, J. R. (2018) · doi:10.11606/d.42.2018.tde-18092018-110513

Phenotypic functional activities of monocyte change during crosstalk with breast cancer cell and enhancing effect of metformin of IFN-γ-associated antitumor cytokine productionPreprint

Dahmani, Z., Addou-Klouche, L., Gizard, F., Dahou, S., Messaoud, A., Djebri, N. C., Benaissti, M. I., Mostefaoui, M., Terbeche, H., Nouari, W., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.14.949412

Allele frequency of promoter region -1082A>G interleukinl0 gene and risk of prostate tumors in Iraqi patients

Al-Ruba’i, S. H. N., Ali, M. S., & Ahmed, N. S. (2021) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1853/1/012024

Examining the Radiation-induced Bystander Effect (RIBE) and its Effect on Metabolism and Inflammation in Gastrointestinal Cancers

Heeran, A. B. (2021) · Arrow@dit (Dublin Institute of Technology)

Allergy and hematological malignancies risk: A possible implication of Immunoglobulin E, TNF-α and Interleukin 10

Shabrawy, R. E., Nagar, A. R. A., & Amin, M. (2021) · Egyptian journal of Immunology · doi:10.55133/eji.280311

Combination therapy of metformin with sodium selenite reverses effects of monotherapy on nitric oxide production, IL-1β and TNF-α release, and upregulates relative expression of Bcl-2 by LPS-activated human primary monocytes in T-cell acute lymphoblastic leukemiaPreprint

Rostane, F., Sari, N., Bali, I., Messali, R., Hadjidj, Z., Miliani, M., Belhassena, I., Mezouar, C. E., & Aribi, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.04.475000

IL-10 Promotes Glioma Cell Growth and Invasion via Upregulation of KPNA2 In vitroPreprint

Zhang, Z., Huang, X., Li, J., Fan, H., Yang, F., Zhang, R., Yang, Y., Feng, S., He, D., Sun, W., et al. (2019) · Research Square · doi:10.21203/rs.2.218/v2

IL-10 Promotes Glioma Cell Growth and Invasion via Upregulation of KPNA2 In vitroPreprint

Zhang, Z., Huang, X., Li, J., Fan, H., Yang, F., Zhang, R., Yang, Y., Feng, S., He, D., Sun, W., et al. (2019) · Research Square · doi:10.21203/rs.2.218/v1

Estimation of Interleukin‐10 and Interleukin‐22 levels in the advances of breast cancer

Al-Kilabi, A. J. A. Z., & Alomashi, G. B. A. (2021) · International Journal of Frontiers in Biology and Pharmacy Research · doi:10.53294/ijfbpr.2021.1.1.0005

Targeting cancer-inducing inflammation: Current advancements and future prospects

Chan, Y., Liew, H. S., Pua, L. J. W., Soon, L., Ng, S. W., Tan, J. Z. X., Chellappan, D. K., & Dua, K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00001-2

Interleukin family (IL-2 and IL-1β) as predictive biomarkers in Indian cancer patients: A proof of concept study

Parthasarathy, P., Pramod, M. J., Kasture, P. V., Archana, S., Bhavana, N. V., Rao, J., & Rao, G. (2023) · Journal of Emerging Investigators · doi:10.59720/22-194

Vitamin D and colorectal cancer

Ferrer‐Mayorga, G., Múñoz, A., & González‐Sancho, J. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00039-2

Prostate Cancer and Inflammation

Hashemi, M., Tavakolipour, V., Morovatshoar, R., Samadpour, A., Asheghabadi, P. S., Hadadian, H., Bandsariyan, A., Ghasemi, Z., Orouei, S., AbolfathyNajmabady, N., et al. (2024) · Springer eBooks · doi:10.1007/978-981-97-4612-5_3 · Cited by 1

The role of irisin and cytokines in the etiology of parotid tumors

Akyiğit, A., Solmaz, Ö. A., Kalaycı, M. Z., Sakallıoğlu, Ö., Düzer, S., Özercan, İ. H., Keleş, E., Karlıdağ, T., Kaygusuz, İ., & Yalçın, Ş. (2025) · Biotechnic & Histochemistry · doi:10.1080/10520295.2025.2450406

GUT MICROBIOME IN CANCER: THE NEXT BIG OPPORTUNITY FOR BETTER PATIENT OUTCOMES?

Povšin, J., Sotošek, T., Novak, M., & Breznik, B. (2025) · Slovenian Veterinary Research · doi:10.26873/svr-2029-2024

Cytokine-based immunotherapy in pancreatic cancer

Gordo-Ortiz, A., Ortiz-de-Solórzano, I., & Navarro, F. C. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.03.001

Immunomodulatory effects of Lactobacillus salivarius on inflammatory pathways and cytokine expression in gastric adenocarcinoma cells

Allahverdy, J., Habibi, S., Zonobian, M. A., Mohsenzadegan, M., & Rashidi, N. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102249

Docetaxel Administration via Novel Hierarchical Nanoparticle Reduces Proinflammatory Cytokine Levels in Prostate Cancer Cells

Aalinkeel, R., Sharma, S. M., Mahajan, S. D., Prasad, P. N., & Schwartz, S. A. (2025) · Cancers · doi:10.3390/cancers17111758

The Design and Manipulation Principles of Immunomodulatory Biomaterials

Gao, R., Zhang, Y., Gao, Y., & Feng, Z. (2025) · Royal Society of Chemistry eBooks · doi:10.1039/9781837675739-00024

Preoperative immunonutrition for patients who undergo primary cytoreductive surgery for ovarian cancer

Kahn, R. M., Smith, E. S., Murphy, K., Yeoshoua, E., Russo, L. M., Zhou, Q. X., Iasonos, A. E., Bennetti, G., Ramesh, B., Abu‐Rustum, N. R., et al. (2025) · International Journal of Gynecological Cancer · doi:10.1016/j.ijgc.2025.101980

Crocin and Flavocoxid Inhibit Tumor Growth, Alter Cytokine Levels of (IL-10/Tnf-α), and Promote Caspase-Induced Apoptosis, and Doxorubicin Efficacy

El‐Mowafy, A. M., Abdelaziz, R., Elsherbiny, N. M., Said, E., & Zaki, M. M. A. F. (2025) · Cancer Research Journal · doi:10.11648/j.crj.20251302.12

Distinct CD4 T-Cell Subsets Predict Lung Cancer Immunotherapy Failure and Identify Patients for Dual BlockadePreprint

Figueiredo, A. B., Evangelista, G. F. D. B., Ferreira, S. M. I., Kuil, L. D. M., Faccio, A. T., Cardozo, K. H. M., Carvalho, V. M., Cavalcanti, C. M., BALDERAS, R. S., Lopes, R. P., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5368719

Mesothelin in pancreatic cancer: clinical applications and analytical considerations

Patel, N. K., Gupta, A., Mishra, R., Menon, S. V., Ray, S., Pandey, S. N., Goyal, K., Ali, H., Maji, C., Rekha, A., et al. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120686

Therapeutic advances: Modulating gut microbiota, ROS, and SCF pathways in cancer treatment

Giri, S., Irfan, Z., & Firdous, S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33459-7.00010-7

Additional file 2 of AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway

Pokhrel, R. H., Acharya, S., Ahn, J.-H., Gu, Y., Pandit, M., Kim, J., 박윤용, Kang, B., Ko, H.-J., & Chang, J.-H. (2021) · Figshare · doi:10.6084/m9.figshare.16816005

Additional file 1 of Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells

Han, N., Anwar, D., Hama, N., Kobayashi, T., Suzuki, H., Takahashi, H., Wada, H., Otsuka, R., Baghdadi, M., & Seino, K.-I. (2020) · Figshare · doi:10.6084/m9.figshare.13088089

Additional file 1 of CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration

Fan, T., Xue, L., Dong, B., He, H., Zhang, W., Hao, L., Ma, W., Zang, G., Han, C., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21184240

Additional file 1 of AMPK promotes antitumor immunity by downregulating PD-1 in regulatory T cells via the HMGCR/p38 signaling pathway

Pokhrel, R. H., Acharya, S., Ahn, J.-H., Gu, Y., Pandit, M., Kim, J., 박윤용, Kang, B., Ko, H.-J., & Chang, J.-H. (2021) · Figshare · doi:10.6084/m9.figshare.16816002

Additional file 2 of CDH1 overexpression predicts bladder cancer from early stage and inversely correlates with immune infiltration

Fan, T., Xue, L., Dong, B., He, H., Zhang, W., Hao, L., Ma, W., Zang, G., Han, C., & Dong, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21184243

Additional file 2 of Bromodomain-containing protein 4 regulates interleukin-34 expression in mouse ovarian cancer cells

Han, N., Anwar, D., Hama, N., Kobayashi, T., Suzuki, H., Takahashi, H., Wada, H., Otsuka, R., Baghdadi, M., & Seino, K.-I. (2020) · Figshare · doi:10.6084/m9.figshare.13088092

Adrenergic signaling induces a pro-tumorigenic B cell state in colorectal cancerPreprint

Thijssen, M. S., Schonkeren, S. L., Coolkens, L., Zou, Y., Temmerman, L., de Vaan, J., Idris, M., Vranken, J., Wouters, K., Vaes, N., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.23.700260

Mathematical modeling of breast cancer: Analyzing immune-chemotherapy interactions and sensitivity to key parameters

Gholami, H., Gachpazan, M., Erfanian, M., & Hasanzadeh, M. (2026) · Advances in Cancer Biology - Metastasis · doi:10.1016/j.adcanc.2026.100179

Role of the tumor suppressor Adenomatous Polyposis Coli in T cell migration and anti-tumor immunity

Mastrogiovanni, M. (2021) · theses.fr (ABES) · doi:10.70675/3c1ae4eez8512z4620z9afdz6e0223471fb6

Optimisation des vaccins peptidiques anti-cancers à but thérapeutique par l'utilisation d'un vecteur omposé de nanotubes de nitrure de bore et combinaisons avec les anticorps anti-PD-L

Rangan, L. (2020) · theses.fr (ABES) · doi:10.70675/b07e22f8z2334z4497z89b0ze8df4b6869cd

Microbiome and cancer prevention

Khan, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40551-8.00009-3

Circulating cell populations as response predictors and targets to improve immunotherapy in metastatic lung cancer

Figueiredo, A. B., Evangelista, G. F. D. B., Ferreira, S. M. I., Kuil, L. D. M., Barbeta, G., Iohan, L. D. C. C., Faccio, A. T., Cardozo, K. H., Carvalho, V. M., Cavalcanti, C. M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116124

Mechanistic interactions between Plasmodium falciparum and Epstein-Barr virus in endemic Burkitt Lymphoma pathogenesis: a narrative review (2010–2026)

Msami, N. A. (2026) · Infectious Agents and Cancer · doi:10.1186/s13027-026-00780-5

Deciphering interleukin 10’s dual role: insights into B cell dynamics in breast tumor-draining lymph nodes

Absalan, F., Ghods, A., Hakimi, H., Shariat, M., Talei, A. R., Mehdipour, F., Rafatpanah, H., & Ghaderi, A. A. (2026) · Central European Journal of Immunology · doi:10.5114/ceji/209026

Laser-Generated Ultrashort Pulsed Electron Beams Induce p53-Related Alteration of DNA Repair and Cell Death Pathways in Non-Small Cell Lung Cancer Cells

Pustovalova, M. V., Pugacheva, P. A., Vorobyeva, N. Y., Babayan, N., Chigasova, A. K., Osipov, A., Sargsyan, A., Tadevosyan, G., Grigoryan, R., Sarkisyan, N., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27167215

Beyond local control: radiotherapy–immunotherapy combinations from in situ vaccination to systemic immune remodeling

Wen, Y., Cheng, N., Zhou, S., Zhu, H., & Ge, Q. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1927654

IL-10 in cancer: Just a classical immunosuppressive factor or also an immunostimulating one?

Berti, F. C. B., & de Oliveira, K. B. (2018) · AIMS Allergy and Immunology · doi:10.3934/allergy.2018.2.88 · Cited by 24

Interleukin-10 and the immune response against cancer: a counterpoint

D, S. M. M., Marincola, F. M., & Young, H. A. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0705358 · Cited by 407

Effect of IL-10 in tumor

Zhou, J., & Tao, L. (2013) · Guoji zhongliuxue zazhi · doi:10.3760/cma.j.issn.1673-422x.2013.03.006

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

Sato, T., Terai, M., Tamura, Y., Alexeev, V. Y., Mastrangelo, M. J., & Selvan, S. R. (2011) · Immunologic Research · doi:10.1007/s12026-011-8262-6 · Cited by 287

Role of IL-10 in Cancer

Marincola, F. M. (2006) · CRC Press eBooks · doi:10.1201/9781498713405-21